Literature DB >> 2360504

Percutaneous cardiopulmonary bypass support in the catheterization laboratory: technique and complications.

F A Shawl1, M J Domanski, M H Wish, M Davis.   

Abstract

A safe and easily applied technique of percutaneous cardiopulmonary bypass support has been developed for use in the cardiac catheterization laboratory. The importance of this technique lies in its ability to maintain hemodynamic stability during high risk interventional procedures regardless of intrinsic cardiac function. Venous and arterial cannulas (18F) are inserted percutaneously over a stiff guide wire after sequential dilatation with 12F and 14F dilators. Bypass flow rates of up to 5 L/min can be achieved. This technique can be applied to support patients with cardiac arrest, hemodynamic collapse after abrupt closure during coronary angioplasty, and cardiogenic shock, as well as those undergoing high-risk elective coronary angioplasty. This form of support also permits transport of the patient to the operating room in a stable condition after an unsuccessful angioplasty. The complications are mostly related to cannula removal and can be minimized by the use of a proper technique. Although the ultimate role of this new technique remains to be completely defined, it appears that it will expand the patient population for whom coronary interventions can be applied.

Entities:  

Mesh:

Year:  1990        PMID: 2360504     DOI: 10.1016/0002-8703(90)90178-z

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Therapeutic strategy of perioperative use of percutaneous cardiopulmonary bypass support (PCPS) for adult cardiac surgery.

Authors:  S Sasaki; K Yasuda; Y Matsui; K Aoi; S Gando; O Kemmotsu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-01

2.  Earlier application of percutaneous cardiopulmonary support rescues patients from severe cardiopulmonary failure using the APACHE III scoring system.

Authors:  Suk-Won Song; Hong-Suk Yang; Sak Lee; Young-Nam Youn; Kyung-Jong Yoo
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.